Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 09, 2025 09:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium

Myriad Genetics will present new data in eight abstracts at the 2025 San Antonio Breast Cancer Symposium (SABCS).
November 25, 2025 16:15 ET | Source: Myriad Genetics, Inc.

Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health

Clairity, Myriad Genetics, and MagView announce a joint collaboration in an effort to identify more women at high risk for breast cancer.
May 07, 2025 16:30 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology

SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced today that JCO Precision Oncology...
February 27, 2025 16:15 ET | Source: Myriad Genetics, Inc.

Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools

Myriad Genetics announced a collaboration with Gabbi to provide an integrated offering for breast cancer risk assessment.
January 09, 2025 16:30 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History

Myriad Genetics announced it signed an agreement with sports broadcaster Hannah Storm to promote the importance of knowing family cancer history.
December 19, 2024 16:15 ET | Source: Myriad Genetics, Inc.

Myriad Genetics’ RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics

Myriad Genetics announced a MyRisk® Hereditary Cancer Test with RiskScore® study was named as one of the top 10 significant advances in genomic medicine.
December 09, 2024 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium

Myriad Genetics, Inc. announced it will present new data at the 2024 San Antonio Breast Cancer Symposium.
June 03, 2024 16:05 ET | Source: Myriad Genetics, Inc.

Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

SALT LAKE CITY, June 03, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that Genetics in Medicine, an official...
August 22, 2023 09:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk

SALT LAKE CITY, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Onsite Women’s Health, a leading national provider of...
July 24, 2023 08:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Announces Inclusion of Breast Density to MyRisk® with RiskScore® Breast Cancer Risk Assessment

RiskScore is the first validated risk model that includes breast density, personal/family history and genetic markers This comprehensive model is expected to identify more patients that could benefit...